SHORT MINI-FUTURE - ABBOTT LABORATORIES Stock

Certificat

DE000VU0H625

Delayed Deutsche Boerse AG 10:53:31 2024-06-28 am EDT
3.22 EUR 0.00% Intraday chart for SHORT MINI-FUTURE - ABBOTT LABORATORIES
Current month-5.85%
1 month-0.31%
Date Price Change
24-06-28 3.22 0.00%
24-06-27 3.22 +2.22%
24-06-26 3.15 +1.29%
24-06-25 3.11 0.00%
24-06-24 3.11 -0.32%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 10:53 am EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Vontobel Vontobel
WKN VU0H62
ISINDE000VU0H625
Date issued 2022-12-05
Strike 138.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.05
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.57
Lowest since issue 1.59
Spread 0.01
Spread %0.31%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
104.6 USD
Average target price
125.2 USD
Spread / Average Target
+19.60%
Consensus